SEC 13F Intelligence

Palo Alto Investors LP / AMAG

Palo Alto Investors LP’s Amag Pharmaceuticals Inc Position

Does Palo Alto Investors LP own Amag Pharmaceuticals Inc (AMAG)? Not currently — the last reported position was 3.00M shares worth $28M in Q3 2020; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$28M
Q3 2020
Shares
3.00M
% of Portfolio
+1.55%
Quarters Held
8
position exited

Position History AMAG

Reported value by quarter
Q4 ’18: $51MQ4 ’18Q1 ’19: $44MQ1 ’19Q2 ’19: $34MQ2 ’19Q3 ’19: $36MQ3 ’19Q4 ’19: $37MQ4 ’19Q1 ’20: $19MQ1 ’20Q2 ’20: $23MQ2 ’20Q3 ’20: $28MQ3 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20203.00M$28M+1.55%
Q2 20202.96M$23M+1.36%
Q1 20203.00M$19M+1.55%
Q4 20193.04M$37M+2.04%
Q3 20193.08M$36M+2.37%
Q2 20193.38M$34M+1.64%
Q1 20193.42M$44M+1.84%
Q4 20183.38M$51M+2.73%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Palo Alto Investors LP’s full portfolio or all institutional holders of AMAG.